Results 61 to 70 of about 10,863 (191)

MODERN INDICATIONS FOR THE USE OF OPIPRAMOL [PDF]

open access: yes, 2015
Opipramol is considered as a pharmacological agent that does not fit the classification taking into account the division of antidepressants, antipsychotics and anxiolytics.
J. Cubała, Wiesław   +8 more
core   +1 more source

COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS [PDF]

open access: yes, 2009
Depressive disorders are more common in the population affected with dermatologic disorders. Comorbidity of depression and dermatologic disorders is around 30%. The correlation between depressive and dermatologic disorders still remains unclear.
Anamarija Petek   +4 more
core   +1 more source

[Neurological complications of tricyclic antidepressive agents].

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1984
The tricyclics are antidepressive drugs in widest use today. They are one of the most effective of the psychotropic agents and would be used more often if it was not for the complications. In this article we consider the neurological stimulation that results in undesirable cardio-vascular responses that are the main side-effects of these drugs.
J P, Chabannes   +4 more
openaire   +1 more source

Antidepressants versus placebo for depression in primary care [PDF]

open access: yes, 2009
Arroll, Bruce   +7 more
core   +2 more sources

Antidepressants in epilepsy [PDF]

open access: yes, 2019
People with epilepsy (PWE) frequently suffer from comorbid mood and anxiety disorders. Depression is one of the major psychiatric comorbidities having a negative impact on the quality of life in people with epilepsy.
Cubała, Wiesław Jerzy   +4 more
core   +1 more source

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

open access: yes, 2008
Antidepressant monotherapy is a first-line treatment for depression; however, not all sufferers will adequately respond to treatment. When treating a patient with treatment-resistant depression, the clinician needs to consider all factors which may ...
Beasley   +47 more
core   +1 more source

Acute and repeated treatment with the 5-HT_7 receptor antagonist SB 269970 induces functional desensitization of 5-HT_7 receptors in rat hippocampus [PDF]

open access: yes, 2012
Bobula, Bartosz   +8 more
core   +1 more source

Antidepressants in Inflammatory Bowel Disease: : A systematic review [PDF]

open access: yes, 2017
Macer, Benjamin   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy